HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Peter B Barker Selected Research
Peter B Barker Research Topics
Disease
17
Neoplasms (Cancer)
08/2023 - 12/2004
9
Schizophrenia (Dementia Praecox)
01/2022 - 03/2011
7
Cognitive Dysfunction
11/2021 - 04/2005
5
Brain Neoplasms (Brain Tumor)
03/2024 - 02/2006
5
Glioblastoma (Glioblastoma Multiforme)
08/2023 - 01/2022
5
HIV Infections (HIV Infection)
01/2020 - 02/2010
4
Glioma (Gliomas)
01/2021 - 11/2013
3
Psychotic Disorders (Schizoaffective Disorder)
03/2024 - 01/2019
3
Adrenoleukodystrophy (Adrenoleukodystrophy, X-Linked)
04/2023 - 10/2002
3
Restless Legs Syndrome (Restless Legs)
01/2016 - 02/2009
2
Mitochondrial Diseases (Mitochondrial Disease)
01/2023 - 01/2003
2
Central Nervous System Diseases (CNS Diseases)
01/2023 - 03/2014
2
Astrocytoma (Pilocytic Astrocytoma)
01/2021 - 05/2005
2
Brain Diseases (Brain Disorder)
01/2019 - 05/2018
2
Dementia (Dementias)
01/2018 - 02/2010
2
Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
02/2014 - 08/2013
2
Multiple Sclerosis
12/2012 - 05/2012
2
Atrophy
02/2012 - 06/2011
2
Breast Neoplasms (Breast Cancer)
12/2010 - 01/2004
2
Infections
10/2010 - 02/2010
2
Sarcoma (Soft Tissue Sarcoma)
07/2010 - 06/2007
2
Bone Cysts (Bone Cyst)
07/2010 - 06/2007
2
Neurofibroma
07/2010 - 06/2007
2
Lipoma (Lipomata)
07/2010 - 06/2007
2
Hematoma
07/2010 - 01/2005
2
Sturge-Weber Syndrome (Sturge-Kalischer-Weber Syndrome)
08/2006 - 10/2003
1
Demyelinating Diseases (Demyelinating Disease)
04/2023
1
Ataxia (Dyssynergia)
12/2022
1
Substance-Related Disorders (Drug Abuse)
01/2022
1
Mental Disorders (Mental Disorder)
01/2022
1
Nocturnal Enuresis (Bedwetting)
12/2021
1
Mood Disorders (Mood Disorder)
11/2021
1
Major Depressive Disorder (Major Depressive Disorders)
11/2021
1
Ketosis
01/2021
1
Encephalitis (Encephalitis, Rasmussen)
01/2018
1
Facioscapulohumeral Muscular Dystrophy
01/2018
1
succinic semialdehyde dehydrogenase deficiency
07/2016
1
Iron Deficiencies
01/2016
1
Alzheimer Disease (Alzheimer's Disease)
05/2015
1
Intracranial Hemorrhages (Intracranial Hemorrhage)
07/2014
1
Ischemic Stroke
07/2014
1
Myositis (Idiopathic Inflammatory Myopathies)
07/2013
1
Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
12/2012
1
Neurodegenerative Diseases (Neurodegenerative Disease)
01/2012
1
Disease Progression
01/2012
1
Pathologic Complete Response
12/2010
1
Virus Diseases (Viral Diseases)
10/2010
1
Giant Cell Tumors (Giant Cell Tumor)
07/2010
Drug/Important Bio-Agent (IBA)
32
Protons (Proton)
IBA
03/2024 - 05/2002
9
Choline (Choline Chloride)
IBA
07/2023 - 01/2006
8
N-acetylaspartate (N-acetyl aspartate)
IBA
03/2024 - 01/2005
7
Glutamic Acid (Glutamate)
FDA Link
01/2021 - 01/2009
6
Biomarkers (Surrogate Marker)
IBA
07/2023 - 01/2012
5
gamma-Aminobutyric Acid (GABA)
IBA
12/2021 - 01/2013
4
Amides
IBA
08/2023 - 11/2013
4
Lactic Acid (Lactate)
FDA Link
Generic
01/2023 - 01/2003
4
Glutamine (L-Glutamine)
FDA Link
04/2016 - 01/2009
3
Glutathione (Reduced Glutathione)
IBA
05/2023 - 05/2018
3
Indicators and Reagents (Reagents)
IBA
01/2021 - 11/2010
2
N-(gamma-aminobutyryl)glutamic acid
IBA
01/2021 - 09/2013
2
Aminobutyrates (Aminobutyric Acid)
IBA
07/2016 - 05/2015
2
Gadolinium
IBA
11/2013 - 09/2007
2
Neurotransmitter Agents (Neurotransmitter)
IBA
09/2013 - 08/2013
2
Sodium
IBA
12/2010 - 12/2004
1
25-hydroxyvitamin D
IBA
04/2023
1
Cholecalciferol (Vitamin D3)
FDA Link
04/2023
1
Vitamin D
FDA Link
Generic
04/2023
1
Temozolomide (Temodar)
FDA Link
Generic
01/2022
1
belinostat
IBA
01/2022
1
Psilocybin (Psilocibin)
IBA
11/2021
1
Ketones
IBA
01/2021
1
Antipsychotic Agents (Antipsychotics)
IBA
01/2021
1
Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))
IBA
01/2021
1
Messenger RNA (mRNA)
IBA
12/2020
1
metabotropic glutamate receptor 3 (mGluR3)
IBA
12/2020
1
Polytetrafluoroethylene (Teflon)
FDA Link
01/2019
1
Antioxidants
IBA
05/2018
1
Succinate-Semialdehyde Dehydrogenase (Succinic Semialdehyde Dehydrogenase)
IBA
07/2016
1
Acids
IBA
07/2016
1
Iron
IBA
01/2016
1
Tissue Plasminogen Activator (Alteplase)
FDA Link
07/2014
1
APT
IBA
11/2013
1
isospaglumic acid (NAAGA)
IBA
09/2013
1
Neuropeptides
IBA
09/2013
1
Butyric Acid (Butanoic Acid)
IBA
01/2013
1
Glutamate Carboxypeptidase II (N-Acetylaspartylglutamate Peptidase)
IBA
12/2012
1
Glutamate Receptors (Glutamate Receptor)
IBA
03/2011
1
N-Methylaspartate (NMDA)
IBA
03/2011
1
Estrogen Receptors
IBA
12/2010
1
Immunologic Factors (Immunomodulators)
IBA
10/2010
1
Macrophage Colony-Stimulating Factor
IBA
10/2010
Therapy/Procedure
11
Therapeutics
04/2023 - 01/2005
3
Highly Active Antiretroviral Therapy (HAART)
01/2018 - 06/2011
2
Radiotherapy
01/2023 - 01/2022
2
Aftercare (After-Treatment)
01/2019 - 07/2014
1
Activities of Daily Living (ADL)
12/2022
1
Transcranial Magnetic Stimulation
01/2022
1
Adjuvant Chemotherapy
01/2021
1
Neurosurgical Procedures
01/2017
1
Drug Therapy (Chemotherapy)
12/2010